ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FDBK Feedback Plc

60.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 14,770 07:44:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 6676 to 6695 of 14875 messages
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older
DateSubjectAuthorDiscuss
27/9/2019
15:31
C,Mon ! Anyone who thinks that was advantageous to FDBK and Its current topical positive sentiment needs to sell all investments and stay in the garden , They have excelled in idiocy this afternoon even by my low opinion of them ,
botak54
27/9/2019
15:30
Very badly worded RNS.
I said earlier they had missed a trick.
All that was needed was to remind investors Texrad was core to Stonechecker and that they do indeed have a royalty agreement in place and further info will be released in time.
But these clueless idiots come out to say almost that they don't even know if Texrad is part of Stonechecker when the whole world knows this to be the case.
Except our bod.

petekand
27/9/2019
15:29
Ah we seem to be bouncing back.
I think what Feedback don't seem to realise is that it is quite common for companies in the same sector to react well when one of them has news .
They do not have to necessarily be related.
For example I have seen a take-over be announced for one firm , which makes investors hopeful for a company in the same sector sometimes.

hazl
27/9/2019
15:26
this will move dyor
bubsy2
27/9/2019
15:22
Hi Ged5, not sure I read that as being negative. They are reviewing the situation and likely impact upon revenue (bare in mind BG is a director of both companies). They also commit to a further announcement in due course and doubtless the TexRAD update will now include FDA considerations.
I understand Bleepa is taking precedence only 4 weeks from expo, but there is a lot in the pipeline that could be transformational. I would have been far more disappointed had TO made no comment at all.
The next month or two could be very interesting, dyor and imo of course.

bobd29
27/9/2019
15:14
Lets see if toptradersadvfn can make money out of his pathetic 2 x 50k buys at 1.1p

I think he'll dump them if he can get 1.2p bid for them

Watch closely, they will 1/2 seconds apart when he sells

dave4545
27/9/2019
15:13
Pete, I've never had a problem with IQAI products, I have a problem with two thirds of the IQAI board. I don't like liars and tend to debate (argue) with them. Perhaps that is to my detriment as liars so rarely ever change their ways.

I also prefer a balanced board where all views are welcome. I had some soul searching to do when you asked me not to post limits (when bad) regularly as that became an issue of freedom of information for me. I still don't like not doing so but to keep the peace I did as you requested (except when you took a summer sabbatical) . However, I refuse to shut up when attacked by Hazl. If Hazl can maintain a balanced viewpoint and also stop having digs at me then I suspect my posts will not be an annoyance to either herself or you.

lr2
27/9/2019
15:12
They should have released that RNS to some circus music and a gif of a clown going round on a miniature bike.
dplewis1
27/9/2019
15:11
I'm assuming when they gave away Texrad technology to Iqai for peanuts and 'future royalties,' they had nothing in place such as an agreed percentage or something of this nature?
They may as well give it away to everyone.

petekand
27/9/2019
15:04
I'm not sure why they bothered. The price was only up about 10-15%

It's not like it was 50-100% up so no need to say anything imo

dave4545
27/9/2019
15:03
I must say what a pathetic statement from our bod who again show their clueless nature.
Texrad technology belongs to us yet this stupid bod know nothing about it.
Iqai may as well said great news we've got FDA clearance but we don't know what that means or if we'll make any money!

petekand
27/9/2019
15:01
jeez that didn't read well..
jackjackpaul
27/9/2019
15:01
Its a pitifully worded RNS and people have dumped as a direct result of it. Are the company ruddy stupid?
coldspring
27/9/2019
15:00
Down the hatch Timberrrrr
jammydodger1
27/9/2019
14:59
Just sold out tidy ?
dave4545
27/9/2019
14:59
Well that's a pity but at least they've RNS'd and slowed any over excitement.
paleje
27/9/2019
14:59
I don't think that ought to be read too negatively.
They are just clearing up current facts.

Bleepa ahoy!

hazl
27/9/2019
14:58
Seems like the income from IQAI is minimal that's why they have come out with the statement
sonie01
27/9/2019
14:55
RNS Number : 0086OFeedback PLC27 September 2019Feedback plcStatement re share priceCambridge, 27 September 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company") notes the movement in the share price today. The Company notes the announcement earlier today by IQ-AI Ltd that Imaging Biometrics, IQ-AI's Milwaukee based subsidiary, today received notification that the FDA has cleared StoneChecker Software for marketing in the USA ("the FDA Clearance"). Stonechecker is a licensee of Feedback's TexRAD(R) software and the Directors believe that the Stonechecker Software uses TexRAD(R) . However, the Company is currently not able to evaluate what level of income, if any, will accrue as a result of the FDA Clearance. In addition, the FDA Clearance does not confer FDA clearance for TexRAD(R) and the Directors are now evaluating the implications of this as part of their ongoing strategic review.A further announcement will be made in due course.
tidy 2
27/9/2019
14:47
LR2
I'm not getting into this with you except to say that I have not been impressed with your behaviour towards Hazl a genuine new investor who came on board off the back off Bleepa.
Yes, he did accuse you of being Botak, which is wrong, but that was only a few days back. You've been hammering him without good reason ever since he invested here.
I also note your first post today after I mentioned your name but a good sportsman would have congratulated Iqai without being prompted particularly after you have been hammering them with your clearly incorrect opinions.
Enough of this nonsense now but I will be watching you closely with regards to Hazl.
Order, order, orrdddder!

petekand
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older

Your Recent History

Delayed Upgrade Clock